Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Feb 15, 2020; 12(2): 219-227
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.219
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.219
Table 1 The clinical characteristics of patients with colorectal cancer, n (%)
| Malignant (n = 350) | Benign (n = 300) | Controls (n = 360) | |
| Age, yr | |||
| < 40 | 10 (2.86) | 16 (5.33) | 63 (17.5) |
| 40-60 | 149 (42.57) | 143 (47.67) | 258 (71.67) |
| ≥ 60 | 191 (54.57) | 141 (47) | 39 (10.83) |
| Gender | |||
| Male | 217 (62) | 200 (66.67) | 212 (58.89) |
| Female | 133 (38) | 100 (33.33) | 148 (41.11) |
| T | |||
| T1-2 | 67 (19.14) | ||
| T3-4 | 235 (67.14) | ||
| Lymph node | |||
| Yes | 165 (47.14) | ||
| No | 119 (34) | ||
| Metastasis | |||
| Yes | 30 (8.57) | ||
| No | 320 (91.43) | ||
| 0 | 2 (0.58) | ||
| TNM Stage | |||
| I | 56 (16) | ||
| II | 108 (30.86) | ||
| III | 106 (30.29) | ||
| IV | 30 (8.57) | ||
| Non | 48 (13.7) | ||
- Citation: Song WY, Zhang X, Zhang Q, Zhang PJ, Zhang R. Clinical value evaluation of serum markers for early diagnosis of colorectal cancer. World J Gastrointest Oncol 2020; 12(2): 219-227
- URL: https://www.wjgnet.com/1948-5204/full/v12/i2/219.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i2.219